XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Additional Paid-in Capital
Accumulated Deficit
Common Stock
Class A Common Stock
Common Stock
Class B Common Stock
Balance at Dec. 31, 2021 $ 186,227 $ 322,540 $ (136,320) $ 5 $ 2
Balance (in shares) at Dec. 31, 2021       55,277,061 15,055,288
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (23,775)   (23,775)    
Stock-based compensation expense 4,111 4,111      
Balance at Mar. 31, 2022 166,563 326,651 (160,095) $ 5 $ 2
Balance (in shares) at Mar. 31, 2022       55,277,061 15,055,288
Balance at Dec. 31, 2021 186,227 322,540 (136,320) $ 5 $ 2
Balance (in shares) at Dec. 31, 2021       55,277,061 15,055,288
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (46,934)        
Balance at Jun. 30, 2022 150,508 333,755 (183,254) $ 5 $ 2
Balance (in shares) at Jun. 30, 2022       55,312,656 15,055,288
Balance at Mar. 31, 2022 166,563 326,651 (160,095) $ 5 $ 2
Balance (in shares) at Mar. 31, 2022       55,277,061 15,055,288
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (23,159)   (23,159)    
Issuance of restricted stock       19,220  
Exercise of stock options 2 2      
Exercise of stock options (in shares)       16,375  
Stock-based compensation expense 7,102 7,102      
Balance at Jun. 30, 2022 150,508 333,755 (183,254) $ 5 $ 2
Balance (in shares) at Jun. 30, 2022       55,312,656 15,055,288
Balance at Dec. 31, 2022 123,722 333,199 (209,484) $ 5 $ 2
Balance (in shares) at Dec. 31, 2022       55,622,488 15,055,288
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (12,160)   (12,160)    
Issuance of restricted stock       324,296  
Exercise of stock options 49 49      
Exercise of stock options (in shares)       54,211  
Stock-based compensation expense 1,126 1,126      
Balance at Mar. 31, 2023 112,737 334,374 (221,644) $ 5 $ 2
Balance (in shares) at Mar. 31, 2023       56,000,995 15,055,288
Balance at Dec. 31, 2022 123,722 333,199 (209,484) $ 5 $ 2
Balance (in shares) at Dec. 31, 2022       55,622,488 15,055,288
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss $ (22,797)        
Exercise of stock options (in shares) 117,867        
Balance at Jun. 30, 2023 $ 103,291 335,565 (232,281) $ 5 $ 2
Balance (in shares) at Jun. 30, 2023       56,284,538 15,055,288
Balance at Mar. 31, 2023 112,737 334,374 (221,644) $ 5 $ 2
Balance (in shares) at Mar. 31, 2023       56,000,995 15,055,288
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (10,637)   (10,637)    
Issuance of restricted stock       219,887  
Exercise of stock options 58 58      
Exercise of stock options (in shares)       63,656  
Stock-based compensation expense 1,133 1,133      
Balance at Jun. 30, 2023 $ 103,291 $ 335,565 $ (232,281) $ 5 $ 2
Balance (in shares) at Jun. 30, 2023       56,284,538 15,055,288